$AMSC
AMERICAN SUPERCONDUCTOR CORP /DE/

2015 Q1 Form 10-Q Financial Statement

#000156459015000491 Filed on February 05, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 Q4 2014 Q3
Revenue $25.13M $21.25M $12.46M
YoY Change 54.29% 3.34% -48.49%
Cost Of Revenue $23.49M $18.09M $13.77M
YoY Change 43.23% 14.06% -39.1%
Gross Profit $1.640M $3.156M -$1.320M
YoY Change -1590.91% -32.85% -184.08%
Gross Profit Margin 6.53% 14.85% -10.6%
Selling, General & Admin $5.680M $7.550M $8.050M
YoY Change -40.15% -8.28% -7.28%
% of Gross Profit 346.34% 239.23%
Research & Development $2.890M $2.795M $3.080M
YoY Change -7.07% -5.29% -0.1%
% of Gross Profit 176.22% 88.56%
Depreciation & Amortization $2.250M $39.00K $2.420M
YoY Change -12.45% -53.57% 2851.22%
% of Gross Profit 137.2% 1.24%
Operating Expenses $8.610M $10.35M $11.17M
YoY Change -31.88% -62.02% -68.28%
Operating Profit -$5.715M -$7.735M -$26.40M
YoY Change -61.58% 15.88% 139.39%
Interest Expense $590.0K $400.0K $500.0K
YoY Change -124.28% -75.0% -85.71%
% of Operating Profit
Other Income/Expense, Net $1.220M -$209.0K $740.0K
YoY Change -1625.0% -38.71% -216.54%
Pretax Income -$3.910M -$6.181M -$25.36M
YoY Change -82.69% -23.83% 77.57%
Income Tax -$550.0K $172.0K $60.00K
% Of Pretax Income
Net Earnings -$3.363M -$6.353M -$25.42M
YoY Change -85.19% -24.52% 73.86%
Net Earnings / Revenue -13.38% -29.9% -204.12%
Basic Earnings Per Share -$0.36 -$0.72 -$3.12
Diluted Earnings Per Share -$0.36 -$0.72 -$3.12
COMMON SHARES
Basic Shares Outstanding 95.72M 8.764M
Diluted Shares Outstanding 8.764M

Balance Sheet

Concept 2015 Q1 2014 Q4 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.50M $36.00M $34.70M
YoY Change -52.44% 1.69% 33.98%
Cash & Equivalents $20.49M $35.98M $35.98M
Short-Term Investments
Other Short-Term Assets $13.60M $13.20M $13.70M
YoY Change 14.29% -36.84% -35.68%
Inventory $20.60M $26.54M $24.50M
Prepaid Expenses
Receivables $9.879M $10.78M $9.700M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $64.55M $86.51M $82.50M
YoY Change -22.49% -3.88% 1.85%
LONG-TERM ASSETS
Property, Plant & Equipment $56.10M $58.26M $60.40M
YoY Change -13.13% -13.31% -13.22%
Goodwill
YoY Change
Intangibles $1.422M $1.565M
YoY Change -28.72%
Long-Term Investments
YoY Change
Other Assets $2.753M $2.833M $11.20M
YoY Change -63.49% -85.09% -42.86%
Total Long-Term Assets $69.27M $70.48M $73.30M
YoY Change -18.72% -20.27% -19.89%
TOTAL ASSETS
Total Short-Term Assets $64.55M $86.51M $82.50M
Total Long-Term Assets $69.27M $70.48M $73.30M
Total Assets $133.8M $157.0M $155.8M
YoY Change -20.58% -12.0% -9.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.062M $7.735M $7.063M
YoY Change 303.77% 49.38% 127.47%
Accrued Expenses $14.30M $27.20M $10.63M
YoY Change -26.29% 49.45% -45.48%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.800M $3.700M $4.800M
YoY Change -38.71% -75.97% -58.62%
Total Short-Term Liabilities $47.20M $65.85M $66.10M
YoY Change -1.3% 14.71% 20.08%
LONG-TERM LIABILITIES
Long-Term Debt $3.900M $4.900M $4.500M
YoY Change -39.06% -32.88% 114.29%
Other Long-Term Liabilities $2.800M $895.0K $3.900M
YoY Change 164.65% -64.2% 229.39%
Total Long-Term Liabilities $6.700M $895.0K $8.400M
YoY Change 533.27% -90.87% 609.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $47.20M $65.85M $66.10M
Total Long-Term Liabilities $6.700M $895.0K $8.400M
Total Liabilities $53.90M $74.51M $74.50M
YoY Change -4.18% 10.88% 24.86%
SHAREHOLDERS EQUITY
Retained Earnings -$901.7M
YoY Change
Common Stock $985.9M $984.4M
YoY Change 1.94%
Preferred Stock
YoY Change
Treasury Stock (at cost) $771.0K
YoY Change
Treasury Stock Shares $34.07K
Shareholders Equity $79.89M $82.48M $81.30M
YoY Change
Total Liabilities & Shareholders Equity $133.8M $157.0M $155.8M
YoY Change -20.6% -12.0% -9.69%

Cashflow Statement

Concept 2015 Q1 2014 Q4 2014 Q3
OPERATING ACTIVITIES
Net Income -$3.363M -$6.353M -$25.42M
YoY Change -85.19% -24.52% 73.86%
Depreciation, Depletion And Amortization $2.250M $39.00K $2.420M
YoY Change -12.45% -53.57% 2851.22%
Cash From Operating Activities -$11.75M -$9.560M -$5.860M
YoY Change -330.39% 166.3% 7.13%
INVESTING ACTIVITIES
Capital Expenditures -$60.00K -$170.0K -$220.0K
YoY Change 0.0% 70.0% 1000.0%
Acquisitions
YoY Change
Other Investing Activities -$2.490M $2.260M $2.760M
YoY Change 654.55% 113.21% -990.32%
Cash From Investing Activities -$2.550M $2.100M $2.530M
YoY Change 553.85% 118.75% -866.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $9.100M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -970.0K 8.910M 1.470M
YoY Change -131.8% -25.87% -238.68%
NET CHANGE
Cash From Operating Activities -11.75M -9.560M -5.860M
Cash From Investing Activities -2.550M 2.100M 2.530M
Cash From Financing Activities -970.0K 8.910M 1.470M
Net Change In Cash -15.27M 1.450M -1.860M
YoY Change -296.78% -84.56% -72.89%
FREE CASH FLOW
Cash From Operating Activities -$11.75M -$9.560M -$5.860M
Capital Expenditures -$60.00K -$170.0K -$220.0K
Free Cash Flow -$11.69M -$9.390M -$5.640M
YoY Change -326.55% 169.05% 3.49%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Period End Date
DocumentPeriodEndDate
2014-12-31
CY2014Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1995000
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Registrant Name
EntityRegistrantName
AMERICAN SUPERCONDUCTOR CORP /DE/
dei Document Type
DocumentType
10-Q
CY2014Q4 us-gaap Deferred Tax Liabilities Gross Current
DeferredTaxLiabilitiesGrossCurrent
7724000
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
983406000
us-gaap Sales Revenue Net
SalesRevenueNet
67830000
CY2014Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
7724000
CY2013Q4 us-gaap Costs And Expenses
CostsAndExpenses
27238000
CY2014Q1 us-gaap Deferred Tax Liabilities Gross Current
DeferredTaxLiabilitiesGrossCurrent
7761000
CY2014Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
966390000
dei Amendment Flag
AmendmentFlag
false
CY2013Q4 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1634000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1555000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-7250000
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-856389000
CY2014Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1058000
CY2014Q1 us-gaap Treasury Stock Value
TreasuryStockValue
370000
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1839000
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
112259000
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
47822000
CY2014Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
990000
CY2013Q4 us-gaap Sales Revenue Net
SalesRevenueNet
20563000
CY2014Q1 us-gaap Liabilities
Liabilities
56250000
CY2014Q4 us-gaap Assets
Assets
156989000
CY2014Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
789000
CY2014Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
9456000
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1508000
CY2014Q1 us-gaap Notes Payable Current
NotesPayableCurrent
6240000
CY2014Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2601000
CY2014Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
6380000
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
168509000
us-gaap Cost Of Revenue
CostOfRevenue
43953000
us-gaap Sales Revenue Net
SalesRevenueNet
45401000
CY2014Q4 us-gaap Cost Of Revenue
CostOfRevenue
18094000
us-gaap Cost Of Revenue
CostOfRevenue
56461000
CY2014Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2795000
CY2013Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2951000
CY2014Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7541000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8993000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9061000
CY2014Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7550000
CY2013Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8232000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
23534000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
27741000
us-gaap Legal Fees
LegalFees
10188000
CY2013Q4 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
108000
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
5416000
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
872000
CY2013Q4 us-gaap Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
84000
us-gaap Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
118000
us-gaap Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
247000
us-gaap Costs And Expenses
CostsAndExpenses
92202000
CY2014Q1 us-gaap Assets
Assets
168509000
CY2013Q4 us-gaap Cost Of Revenue
CostOfRevenue
15863000
CY2013Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62309000
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Entity Central Index Key
EntityCentralIndexKey
0000880807
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2015Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
95722127
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35983000
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43114000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10778000
CY2014Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2913000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2833000
CY2014Q4 us-gaap Notes Payable Current
NotesPayableCurrent
3694000
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
65845000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
86510000
CY2014Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
24805000
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
961000
CY2014Q4 us-gaap Treasury Stock Value
TreasuryStockValue
771000
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
895000
CY2014Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
21764000
CY2014Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
3914000
CY2014Q4 us-gaap Liabilities
Liabilities
74514000
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
560000
CY2014Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
4868000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-901681000
CY2014Q4 us-gaap Sales Revenue Net
SalesRevenueNet
21250000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
82475000
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
15385000
CY2014Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2906000
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
156989000
CY2014Q1 us-gaap Assets Current
AssetsCurrent
83281000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
58257000
CY2014Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
87645000
CY2014Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-188000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.55
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.55
us-gaap Net Income Loss
NetIncomeLoss
-33553000
CY2014Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-188000
CY2013Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.55
CY2014Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
87645000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
82284000
amsc Gain Loss In Change Of Fair Value Of Derivative Instruments And Warrants
GainLossInChangeOfFairValueOfDerivativeInstrumentsAndWarrants
3048000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1015000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
379000
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-6675000
CY2013Q4 amsc Gain Loss In Change Of Fair Value Of Derivative Instruments And Warrants
GainLossInChangeOfFairValueOfDerivativeInstrumentsAndWarrants
535000
amsc Gain Loss In Change Of Fair Value Of Derivative Instruments And Warrants
GainLossInChangeOfFairValueOfDerivativeInstrumentsAndWarrants
1890000
CY2013Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-341000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-908000
CY2013Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-8115000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-44929000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1279000
CY2013Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60578000
CY2013Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62309000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
82284000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60578000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1279000
CY2013Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
358000
us-gaap Costs And Expenses
CostsAndExpenses
94382000
CY2013Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
358000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-32820000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
363000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
733000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1015000
us-gaap Share Based Compensation
ShareBasedCompensation
7328000
us-gaap Inventory Write Down
InventoryWriteDown
287000
us-gaap Operating Income Loss
OperatingIncomeLoss
-46801000
us-gaap Operating Income Loss
OperatingIncomeLoss
-26552000
us-gaap Gain Loss On Investments
GainLossOnInvestments
-789000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
5902000
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-8417000
us-gaap Net Income Loss
NetIncomeLoss
-45292000
CY2013Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8059000
CY2013Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
302000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-46571000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-32538000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
8052000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3462000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-8682000
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
-6353000
CY2014Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2014Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-8445000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-20575000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-18366000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
223000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
60000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-4700000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-4670000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-316000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
109000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
4355000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
4398000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
400000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
57000
CY2014Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1521000
CY2013Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3040000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4620000
CY2014Q4 amsc Weighted Average Shares Of Common Stock Outstanding
WeightedAverageSharesOfCommonStockOutstanding
91054000
CY2013Q4 amsc Weighted Average Shares Of Common Stock Outstanding
WeightedAverageSharesOfCommonStockOutstanding
64442000
CY2014Q4 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
3409000
CY2013Q4 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
2133000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
99000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
9747000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
369000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-7131000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3849000
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39243000
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35983000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
362000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1623000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
7931000
us-gaap Interest Paid
InterestPaid
937000
us-gaap Interest Paid
InterestPaid
599000
us-gaap Nature Of Operations
NatureOfOperations
<div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1. Nature of the Business and Operations and Liquidity </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Nature of the Business and Operations </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">American Superconductor Corporation (&#8220;AMSC&#8221; or the &#8220;Company&#8221;) was founded on April&#160;9, 1987. The Company is a leading provider of megawatt-scale solutions that lower the cost of wind power and enhance the performance of the power grid. In the wind power market, the Company enables manufacturers to field wind turbines through its advanced engineering, support services and power electronics products. In the power grid market, the Company enables electric utilities and renewable energy project developers to connect, transmit and distribute power through its transmission planning services and power electronics and superconductor-based products. The Company&#8217;s wind and power grid products and services provide exceptional reliability, security, efficiency and affordability to its customers. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These unaudited condensed consolidated financial statements of the Company have been prepared on a going concern basis in accordance with United States generally accepted accounting principles (&#8220;GAAP&#8221;) and the Securities and Exchange Commission&#8217;s (&#8220;SEC&#8221;) instructions to Form 10-Q. The going concern basis of presentation assumes that the Company will continue operations and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. Certain information and footnote disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to those instructions. The year-end condensed balance sheet data was derived from audited financial statements but does not include all disclosures required by GAAP. The unaudited condensed consolidated financial statements, in the opinion of management, reflect all adjustments (consisting of normal recurring adjustments) necessary for a fair statement of the results for the interim periods ended December 31, 2014 and 2013 and the financial position at December 31, 2014. </p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Liquidity </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has experienced recurring operating losses and as of December 31, 2014, the Company had an accumulated deficit of $901.7 million. In addition, the Company has experienced recurring negative operating cash flows.&nbsp;&nbsp;At December 31, 2014, the Company had cash and cash equivalents of $36.0 million. Cash used in operations for the nine months ended December 31, 2014 was $20.9 million.&nbsp;&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On August 29, 2014, the Arbitration Tribunal for the ICC International Court of Arbitration (the &#8220;ICC Court&#8221;) found the Company&#8217;s wholly-owned Austrian subsidiary, AMSC Austria GmbH (&#8220;AMSC Austria&#8221;) liable for damages in its breach of contract proceeding against Ghodawat Energy Pvt Ltd (&#8220;Ghodawat&#8221;) and awarded Ghodawat approximately &#8364;8.3 million (approximately $10.1 million) plus interest of 5.33%, which accrues from the date of award.&nbsp;&nbsp;On February 4, 2015, AMSC Austria entered into a Settlement Agreement with Ghodawat, which provided for, among other things, (i) a payment by AMSC Austria to Ghodawat of &#8364;7.45 million (approximately $8.5 million), and (ii) upon payment by AMSC Austria to Ghodawat, the full settlement of any and all disputes and claims between the parties (including their respective parent and affiliated companies), in particular related to or arising out of the award.&nbsp;&nbsp;As of the date of this filing, the Company has not paid this award, but expects to pay the settlement amount during the fourth quarter of fiscal 2014.&nbsp;&nbsp;See Note 13, &#8220;Commitments and Contingencies&#8221; for further information.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">From April 1, 2011 through the date of this filing, the Company has reduced its global workforce substantially.&nbsp;&nbsp;The Company is currently in the process of consolidating certain business operations to reduce facility costs.&nbsp;&nbsp;As of December 31, 2014, the Company had a global workforce of approximately 303 persons.&nbsp;&nbsp;The Company plans to closely monitor its expenses and if required, expects to further reduce operating costs and capital spending to enhance liquidity. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On June&#160;5, 2012, the Company entered into a Loan and Security Agreement (the &#8220;Term Loan&#8221;) with Hercules Technology Growth Capital, Inc (&#8220;Hercules&#8221;), under which the Company borrowed $10.0 million.&nbsp;&nbsp;As of December 31, 2014, this loan was repaid in full.&nbsp;&nbsp;On November 15, 2013, the Company entered into an amendment of the Term Loan (the &#8220;New Term Loan B&#8221;, under which the Company borrowed an additional $10.0 million.&nbsp;&nbsp;On December 19, 2014, the Company entered into a second amendment of the Term Loan, (the &#8220;New Term Loan C&#8221;) and together with the Term Loan and the New Term Loan B, the &#8220;Term Loans&#8221;), under which the Company borrowed an additional $1.5 million.&nbsp;&nbsp;As of December 31, 2014, the outstanding principal balance of the Term Loans is approximately $9.2 million.&nbsp;&nbsp;The Term Loans contain certain covenants and restrictions including, among others, a requirement to maintain a minimum unrestricted cash balance in the U.S. equal to the lesser of a minimum threshold or the remaining principal balance of the Term Loans.&nbsp;&nbsp;(See Note 10, &#8220;Debt&#8221;, for further information regarding these debt arrangements, including the covenants, restrictions and events of default under the agreements.) The Company believes that it is in compliance with the covenants and restrictions included in the agreements governing these debt arrangements as of December 31, 2014. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On November 15, 2013, the Company entered into an At Market Sales Arrangement (&#8220;ATM&#8221;) under which the Company could, at its discretion, sell up to $30.0 million of shares of its common stock (before expenses) through its sales agent, MLV &amp; Co. LLC (&#8220;MLV&#8221;).&nbsp;&nbsp;During the three months ended December 31, 2014, the Company received net proceeds of $1.0 million, including sales and commissions and offering expenses, from sales of approximately 0.8 million shares of its common stock at an average sales price of approximately $1.22 per share under the ATM. (See Note 12, &#8220;Stockholders&#8217; Equity&#8221;, for further information regarding the ATM.)&nbsp;&nbsp; On November 5, 2014, the Company terminated the ATM arrangement in connection with an equity offering (see further discussion below). </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On November 13, 2014, the Company completed an offering of approximately 9.1 million units of its common stock to a single investor at a price of $1.10 per share.&nbsp;&nbsp;Each unit consisted of one share of the Company&#8217;s common stock and 0.9 of a warrant to purchase one share of common stock, or a warrant to purchase in the aggregate 8.2 million shares.&nbsp;&nbsp;After deducting fees and expenses, the net proceeds from this offering were approximately $9.1 million.&nbsp;&nbsp;(See Note 12, &#8220;Stockholders Equity&#8221; for further discussion regarding this offering.)</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As a result of the financings completed during the three months ended December 31, 2014, the Company believes it has sufficient liquidity to fund its operations, including the Ghodawat arbitration award liability, capital expenditures and scheduled cash payments under its debt obligations through December 31, 2015. The Company&#8217;s liquidity is highly dependent on, its ability to increase revenues, its ability to control its operating costs, its ability to maintain compliance with the covenants and restrictions on its debt obligations (or obtain waivers from its lender in the event of non-compliance), and its ability to raise additional capital, if necessary. There can be no assurance that the Company will be able to continue to raise additional capital from other sources or execute on any other means of improving liquidity described above. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, the Company is actively seeking to sell its minority investment in Tres Amigas, LLC, a Delaware limited liability Company (&#8220;Tres Amigas&#8221;).&nbsp;&nbsp;The Company no longer believes its investment in Blade Dynamics is recoverable and fully impaired its remaining investment in Blade Dynamics Ltd. (&#8220;Blade Dynamics&#8221;) during the three months ended September 30, 2014. (See Note 14, &#8220;Minority Investments&#8221;, for further information about such investments.) There can be no assurance that the Company will be able to sell these investments on commercially reasonable terms or at all.</p></div>
CY2014Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7556000
CY2014Q4 us-gaap Inventory Net
InventoryNet
26536000
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11705000
CY2014Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9004000
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
64574000
CY2014Q1 us-gaap Inventory Net
InventoryNet
20694000
CY2014Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1565000
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
100000
CY2014Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
3394000
CY2014Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
7724000
CY2014Q4 us-gaap Litigation Reserve
LitigationReserve
10323000
CY2014Q4 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
507000
CY2014Q4 us-gaap Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
39000
CY2014Q4 us-gaap Costs And Expenses
CostsAndExpenses
28985000
CY2014Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-7735000
CY2014Q4 amsc Gain Loss In Change Of Fair Value Of Derivative Instruments And Warrants
GainLossInChangeOfFairValueOfDerivativeInstrumentsAndWarrants
2288000
CY2014Q4 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-525000
CY2014Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-209000
CY2014Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6181000
CY2014Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
172000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.55
CY2014Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6541000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
7298000
us-gaap Share Based Compensation
ShareBasedCompensation
4620000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
3464000
us-gaap Inventory Write Down
InventoryWriteDown
1401000
us-gaap Gain Loss On Investments
GainLossOnInvestments
-644000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
490000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
838000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1181000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3434000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-10414000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7598000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3072000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3462000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5694000
amsc Increase Decrease In Litigation Reserve
IncreaseDecreaseInLitigationReserve
10328000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
8409000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-20934000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
681000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
20000
us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
1429000
us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
9838000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
6295000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
5839000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3332000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9114000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
60000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
9750000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-299000
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35394000
CY2014Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
3367000
CY2013Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
3069000
CY2013Q3 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.6626
CY2013Q4 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0012
CY2013Q3 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0010
CY2013Q4 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0.1650
CY2013Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
10411000
CY2013Q4 us-gaap Share Price
SharePrice
1.64
CY2013Q3 us-gaap Share Price
SharePrice
2.34
CY2013Q4 amsc Percentage Volume Condition Met
PercentageVolumeConditionMet
0.8720
CY2013Q3 amsc Percentage Volume Condition Met
PercentageVolumeConditionMet
0.8020
CY2013Q4 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.6863
CY2013Q3 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0.1550
CY2013Q4 amsc Fair Value Assumptions Recovery Rate
FairValueAssumptionsRecoveryRate
0.3500
CY2013Q3 amsc Fair Value Assumptions Recovery Rate
FairValueAssumptionsRecoveryRate
0.3500
amsc Fair Value Assumptions Redeemable
FairValueAssumptionsRedeemable
yes
CY2013Q2 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P1Y3M4D
CY2013Q1 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P1Y6M4D
CY2014Q4 dei Entity Number Of Employees
EntityNumberOfEmployees
303
CY2014Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
9100000
CY2014Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1.10
CY2014Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9100000
CY2014Q4 amsc Warrants To Purchase One Share Of Common Stock
WarrantsToPurchaseOneShareOfCommonStock
0.9
CY2014Q4 amsc Number Of Warrants Issued To Purchase Common Stock
NumberOfWarrantsIssuedToPurchaseCommonStock
8200000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7328000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.855
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.751
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.019
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.017
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M24D
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2014Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15700000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15700000
CY2013Q4 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
100000
CY2014Q4 us-gaap Billed Contract Receivables
BilledContractReceivables
10401000
CY2013Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10100000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10100000
amsc Weighted Average Shares Of Common Stock Outstanding
WeightedAverageSharesOfCommonStockOutstanding
83263000
amsc Weighted Average Shares Of Common Stock Outstanding
WeightedAverageSharesOfCommonStockOutstanding
62256000
us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
979000
us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
1678000
CY2014Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
22516000
CY2014Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
17675000
CY2014Q1 us-gaap Assets Fair Value Disclosure Nonrecurring
AssetsFairValueDisclosureNonrecurring
3690000
CY2014Q1 us-gaap Billed Contract Receivables
BilledContractReceivables
6113000
CY2014Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
393000
CY2014Q1 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
1459000
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
16000
CY2014Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
16000
CY2014Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
8107000
CY2014Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
3304000
CY2014Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
6344000
CY2014Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
4047000
CY2014Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
9450000
CY2014Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
10275000
CY2014Q4 us-gaap Inventory For Long Term Contracts Or Programs
InventoryForLongTermContractsOrPrograms
2635000
CY2014Q1 us-gaap Inventory For Long Term Contracts Or Programs
InventoryForLongTermContractsOrPrograms
3068000
CY2014Q4 us-gaap Inventory Write Down
InventoryWriteDown
100000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7735000
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1749000
CY2014Q4 amsc Accrued Inventories In Transit
AccruedInventoriesInTransit
1811000
CY2014Q1 amsc Accrued Inventories In Transit
AccruedInventoriesInTransit
212000
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3711000
CY2014Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6076000
CY2014Q4 amsc Accrued Outside Services
AccruedOutsideServices
2914000
CY2014Q1 amsc Accrued Outside Services
AccruedOutsideServices
3716000
CY2014Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
60000
CY2014Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
290000
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4230000
CY2014Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5939000
CY2014Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
229000
CY2014Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
173000
CY2014Q1 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
402000
CY2014Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
4115000
CY2014Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
3207000
CY2013Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
2709000
CY2014Q4 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
1309000
CY2013Q4 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
273000
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
2212000
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
767000
CY2014Q4 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
561000
CY2013Q4 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
15000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
1304000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
149000
CY2013Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
3327000
CY2013Q3 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.07
CY2014Q4 us-gaap Severance Costs1
SeveranceCosts1
500000
us-gaap Severance Costs1
SeveranceCosts1
1900000
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
900000
CY2014Q2 us-gaap Restructuring Reserve
RestructuringReserve
844000
us-gaap Restructuring Charges
RestructuringCharges
1952000
us-gaap Payments For Restructuring
PaymentsForRestructuring
2015000
CY2014Q4 us-gaap Restructuring Reserve
RestructuringReserve
781000
CY2013Q1 us-gaap Restructuring Reserve
RestructuringReserve
199000
us-gaap Restructuring Charges
RestructuringCharges
872000
us-gaap Payments For Restructuring
PaymentsForRestructuring
858000
us-gaap Restructuring Reserve Accrual Adjustment
RestructuringReserveAccrualAdjustment
-213000
amsc Percentage Of Stock Discount
PercentageOfStockDiscount
0.85
amsc Number Of Trading Period For Valuation Of Shares
NumberOfTradingPeriodForValuationOfShares
P10D
CY2013Q4 amsc Non Cash Interest Expense Issuing Stock At Discount
NonCashInterestExpenseIssuingStockAtDiscount
1800000
amsc Non Cash Interest Expense Issuing Stock At Discount
NonCashInterestExpenseIssuingStockAtDiscount
1800000
us-gaap Debt Instrument Maturity Date Description
DebtInstrumentMaturityDateDescription
As part of the Hercules Second Amendment, this Minimum Threshold was amended to be the lower of $5.0 million or the aggregate outstanding principal balance of the Term Loans. As of December 31, 2014, the Minimum Threshold was $5.0 million. If the Company raises $10.0 million in new capital by June 30, 2015, the Minimum Threshold will be reduced to the lesser of $2.0 million or the aggregate outstanding principal balance of the Term Loans.
CY2014Q4 us-gaap Interest Expense
InterestExpense
400000
us-gaap Interest Expense
InterestExpense
1400000
CY2013Q4 us-gaap Interest Expense
InterestExpense
1600000
us-gaap Interest Expense
InterestExpense
7200000
CY2014Q4 amsc Non Cash Interest Expense Amortization Of Debt Discount
NonCashInterestExpenseAmortizationOfDebtDiscount
100000
amsc Non Cash Interest Expense Amortization Of Debt Discount
NonCashInterestExpenseAmortizationOfDebtDiscount
500000
CY2013Q4 amsc Non Cash Interest Expense Amortization Of Debt Discount
NonCashInterestExpenseAmortizationOfDebtDiscount
1100000
amsc Non Cash Interest Expense Amortization Of Debt Discount
NonCashInterestExpenseAmortizationOfDebtDiscount
5900000
CY2013Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
10411000
CY2013Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
14389000
CY2013Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
15380000
CY2013Q2 us-gaap Share Price
SharePrice
2.64
CY2013Q1 us-gaap Share Price
SharePrice
2.67
CY2013Q2 amsc Percentage Volume Condition Met
PercentageVolumeConditionMet
0.8750
CY2013Q1 amsc Percentage Volume Condition Met
PercentageVolumeConditionMet
0.8050
CY2013Q2 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.6580
CY2013Q1 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.6691
CY2013Q2 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0021
CY2013Q1 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0020
CY2013Q2 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0.1670
CY2013Q1 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0.1650
CY2013Q2 amsc Fair Value Assumptions Recovery Rate
FairValueAssumptionsRecoveryRate
0.3700
CY2013Q1 amsc Fair Value Assumptions Recovery Rate
FairValueAssumptionsRecoveryRate
0.3000
CY2013Q4 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P9M
CY2013Q3 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P1Y
amsc Fair Value Assumptions Dilution Effect
FairValueAssumptionsDilutionEffect
yes
CY2013Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
200000
CY2013Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
500000
CY2013Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
500000
CY2013Q4 amsc Convertible Notes Fair Value As Percentage Of Par Value
ConvertibleNotesFairValueAsPercentageOfParValue
0.0002
CY2013Q3 amsc Convertible Notes Fair Value As Percentage Of Par Value
ConvertibleNotesFairValueAsPercentageOfParValue
0.0070
CY2013Q2 amsc Convertible Notes Fair Value As Percentage Of Par Value
ConvertibleNotesFairValueAsPercentageOfParValue
0.033
CY2013Q1 amsc Convertible Notes Fair Value As Percentage Of Par Value
ConvertibleNotesFairValueAsPercentageOfParValue
0.034
amsc Convertible Debt Instrument Redemption Waiting Period
ConvertibleDebtInstrumentRedemptionWaitingPeriod
P1Y
amsc Convertible Debt Instrument Contractual Term
ConvertibleDebtInstrumentContractualTerm
P30M
CY2012Q2 invest Investment Warrants Expiration Date
InvestmentWarrantsExpirationDate
2017-12-05
CY2013Q4 invest Investment Warrants Expiration Date
InvestmentWarrantsExpirationDate
2019-05-15
CY2014Q4 us-gaap Common Unit Issued
CommonUnitIssued
9100000
CY2014Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1.10
CY2014Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9100000
CY2014Q4 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
0
CY2014Q4 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
1300000
CY2011Q2 us-gaap Loss Contingency New Claims Filed Number
LossContingencyNewClaimsFiledNumber
7
CY2011Q2 amsc Number Of Officers Putative Securities Filed Against
NumberOfOfficersPutativeSecuritiesFiledAgainst
2
CY2011Q2 amsc Number Of Complaint Additionally Asserted Claims Against Underwriters
NumberOfComplaintAdditionallyAssertedClaimsAgainstUnderwriters
1
CY2013Q4 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
10000000
CY2014Q4 us-gaap Insurance Settlements Receivable
InsuranceSettlementsReceivable
8200000
CY2014Q4 amsc Settlement Amount Expected To Be Paid By Issuance Of Common Stock
SettlementAmountExpectedToBePaidByIssuanceOfCommonStock
1800000
CY2014Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
944882
CY2014Q2 amsc Shortfall Payment
ShortfallPayment
500000
CY2011Q3 amsc Loss Contingency Number Of Claims Consolidated
LossContingencyNumberOfClaimsConsolidated
3
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2

Files In Submission

Name View Source Status
0001564590-15-000491-index-headers.html Edgar Link pending
0001564590-15-000491-index.html Edgar Link pending
0001564590-15-000491.txt Edgar Link pending
0001564590-15-000491-xbrl.zip Edgar Link pending
amsc-10q_20141231.htm Edgar Link pending
amsc-20141231.xml Edgar Link completed
amsc-20141231.xsd Edgar Link pending
amsc-20141231_cal.xml Edgar Link unprocessable
amsc-20141231_def.xml Edgar Link unprocessable
amsc-20141231_lab.xml Edgar Link unprocessable
amsc-20141231_pre.xml Edgar Link unprocessable
amsc-ex102_20141231563.htm Edgar Link pending
amsc-ex311_201412317.htm Edgar Link pending
amsc-ex312_201412318.htm Edgar Link pending
amsc-ex321_2014123110.htm Edgar Link pending
amsc-ex322_201412319.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending